SCHEMBL22989925

SCHEMBL22989925

CCN(CC(F)F)C1CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DPP4 P27487 1/20 0.36
GPR119 Q8TDV5 4/20 0.36
NAMPT P43490 1/20 0.36
USP30 Q70CQ3 1/20 0.36
IDO1 P14902 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
RORC P51449 1/20 0.35
TACR1 P25103 1/20 0.35
HPGD P15428 1/20 0.35
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24161826 0.88 NR1H2 (0.51) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL22989452 0.79 NR1H2 (0.49) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL14697592 0.77 NR1H2 (0.50) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL34473801 0.77 USP30 (0.50) NR1H2GPR119USP30MEN1ALDH1A1
SCHEMBL19918238 0.77 USP30 (0.50) NR1H2GPR119USP30MEN1ALDH1A1
SCHEMBL23917956 0.75 USP30 (0.49) DDB1CRBNDPP4GPR119USP30
SCHEMBL21513225 0.75 GPR119 (0.49) SMN1; SMN2GPR119ALDH1A1MAPTJAK2
SCHEMBL31543215 0.75 NR1H2 (0.48) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL34474589 0.75 NR1H2 (0.48) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL22989769 0.74 NR1H2 (0.44) NR1H2DDB1CRBNUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021027943-A1 PYRIMIDINOPYRIDAZINONE DERIVATIVE AND MEDICAL USE THEREOF 正大天晴药业集团南京顺欣制药有限公司 2021-02-18 WO disclosed